You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for NDC 00078-0972


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00078-0972

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
PROMACTA 12.5MG/PKT POWDER,ORAL Novartis Pharmaceuticals Corporation 00078-0972-61 30 3684.69 122.82300 2020-09-01 - 2025-08-31 Big4
PROMACTA 12.5MG/PKT POWDER,ORAL Novartis Pharmaceuticals Corporation 00078-0972-61 30 5218.34 173.94467 2020-09-01 - 2025-08-31 FSS
PROMACTA 12.5MG/PKT POWDER,ORAL Novartis Pharmaceuticals Corporation 00078-0972-61 30 3637.29 121.24300 2021-01-01 - 2025-08-31 Big4
PROMACTA 12.5MG/PKT POWDER,ORAL Novartis Pharmaceuticals Corporation 00078-0972-61 30 5218.34 173.94467 2021-01-01 - 2025-08-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00078-0972 Market Analysis and Financial Projection

Market Analysis and Price Projections for NDC 00078-0972

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code[4].

Identifying the Drug

The NDC 00078-0972 corresponds to a specific drug product. However, the provided sources do not directly mention this NDC. To proceed, we need to identify the drug associated with this NDC.

General Market Trends in Pharmaceutical Pricing

Pharmaceutical pricing is influenced by several factors, including regulatory changes, market competition, and the introduction of new treatments.

Regulatory Changes

The Biden-Harris Administration's recent initiatives to negotiate lower prescription drug prices for Medicare beneficiaries are significant. For example, the Inflation Reduction Act allows Medicare to negotiate prices for certain high-cost drugs, leading to substantial savings for patients and taxpayers[5].

Market Competition and New Treatments

The pharmaceutical market is highly competitive, especially in areas like oncology and chronic disease management. New treatments, such as immunotherapies and targeted therapies, are driving market growth. For instance, in the Non-Small Cell Lung Cancer (NSCLC) market, immunotherapies like Keytruda, Opdivo, and Tecentriq are projected to dominate sales by 2025, with significant growth expected in targeted therapies as well[3].

Price Projections

Impact of Regulatory Negotiations

If the drug associated with NDC 00078-0972 is one of the high-cost medications targeted by Medicare's price negotiation program, we can expect significant price reductions. For example, drugs like Eliquis, Jardiance, and Januvia have seen negotiated price reductions ranging from 38% to 79%[5].

Market Dynamics

Without specific data on the drug associated with NDC 00078-0972, we can infer from general market trends:

  • Brand Name Drugs: Median price increases for brand name drugs have been around 13.4% in recent years, but this can vary widely depending on the drug and market conditions[2].
  • Generic and Biosimilar Impact: The introduction of generics and biosimilars can significantly reduce prices. For instance, in the NSCLC market, the sales of generic versions of drugs like Tarceva and Alimta are expected to grow, reducing the market share of their branded counterparts[3].

Specific Price Analysis

To provide a precise price projection, one would need to know the specific drug, its current market price, and any upcoming regulatory or market changes that might affect its pricing.

Example Scenario

If the drug associated with NDC 00078-0972 is a high-cost medication similar to those targeted by Medicare's negotiation program, here is a hypothetical scenario:

  • Current Price: Assume the current price for a 30-day supply is $500.
  • Negotiated Price: If the drug is subject to a similar negotiation process, the price could be reduced by 50% to $250 for a 30-day supply, aligning with the savings seen in other negotiated prices[5].

Key Takeaways

  • Regulatory Impact: Changes in regulatory policies, such as Medicare's price negotiation program, can significantly reduce drug prices.
  • Market Competition: The introduction of new treatments and generics/biosimilars can drive down prices and alter market dynamics.
  • Specific Drug Data: To make accurate price projections, detailed information about the specific drug, including its current pricing and market position, is essential.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique, three-segment number that identifies drug products, including the labeler, product, and package code[4].
  2. How do regulatory changes affect drug prices?

    • Regulatory changes, such as Medicare's price negotiation program, can significantly reduce drug prices by allowing for negotiated lower prices[5].
  3. What impact do generics and biosimilars have on drug prices?

    • The introduction of generics and biosimilars typically reduces the prices of branded drugs by providing cheaper alternatives[3].
  4. How can market trends influence drug pricing?

    • Market trends, including the introduction of new treatments and changes in market competition, can drive price adjustments and influence overall market dynamics[3].
  5. Where can I find the most current pricing information for a specific NDC?

    • Current pricing information can often be found through databases like the FDA's NDC Directory or specialized pricing platforms like DrugPatentWatch[1][2].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Latest drug prices and trends for NDC 00378-2245 - DrugPatentWatch
  3. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - GlobalData
  4. National Drug Code Database Background Information - FDA
  5. FACT SHEET: Biden-Harris Administration Announces New, Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation - The White House

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.